UnitedHealth Group (NYSE:UNH) Earns Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of UnitedHealth Group (NYSE:UNHFree Report) in a report published on Tuesday, Benzinga reports. The firm currently has a $591.00 price target on the healthcare conglomerate’s stock.

Several other equities analysts have also recently weighed in on UNH. Baird R W raised UnitedHealth Group to a strong-buy rating in a research report on Thursday, May 30th. Wells Fargo & Company cut their price target on UnitedHealth Group from $600.00 to $525.00 and set an overweight rating for the company in a report on Monday, April 8th. HSBC raised UnitedHealth Group from a hold rating to a buy rating and set a $580.00 price target for the company in a report on Wednesday, June 5th. Truist Financial reaffirmed a buy rating and issued a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, Morgan Stanley dropped their target price on UnitedHealth Group from $618.00 to $584.00 and set an overweight rating for the company in a report on Friday, April 5th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of Moderate Buy and a consensus target price of $581.44.

Get Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

UNH opened at $511.53 on Tuesday. The company has a market cap of $470.81 billion, a PE ratio of 31.27, a price-to-earnings-growth ratio of 1.47 and a beta of 0.60. The stock has a 50-day moving average of $499.58 and a 200-day moving average of $499.99. UnitedHealth Group has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the previous year, the firm earned $6.26 EPS. The firm’s revenue was up 8.6% compared to the same quarter last year. As a group, equities research analysts forecast that UnitedHealth Group will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.64%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date was Monday, June 17th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group in the 4th quarter worth $26,000. CGC Financial Services LLC boosted its position in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. Delos Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the last quarter. True Wealth Design LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $31,000. Finally, LFA Lugano Financial Advisors SA raised its stake in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the period. 87.86% of the stock is currently owned by institutional investors.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.